An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
Open Access
- 25 March 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 20 (8) , 909-915
Abstract
Introduction: About 70 million people worldwide are estimated to suffer from epilepsy. Despite a large variety of old and new antiepileptic drugs on the market, about 30% of people with epilepsy do not become seizure-free with medical treatment. This is a major individual and public health burden. Most of these difficult-to-treat patients are having focal seizures. Zonisamide is effective against focal seizures in adults and children and, thus, a therapeutic option for such patients. Its safety profile needs special attention. Areas covered: Herein, the authors discuss the pharmacology, clinical efficacy and the adverse effects of zonisamide. The article is derived from clinical trial data, long-term studies, meta-analyses, review articles, text books, webpages, and official license information. Expert opinion: Zonisamide has proven to be efficacious in focal epilepsy in children and adults, although it is not more effective than carbamazepine or other antiepileptic drugs. It is also effective in generalized epilepsy and in several other conditions of the CNS. Its safety profile may prevent it from becoming a first-line drug for focal epilepsy or any other indication.Keywords
This publication has 62 references indexed in Scilit:
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia, 2013
- Zonisamide discontinuation due to psychiatric and cognitive adverse eventsNeurology, 2010
- Estimation of the burden of active and life‐time epilepsy: A meta‐analytic approachEpilepsia, 2010
- Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsyActa Neurologica Scandinavica, 2008
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Zonisamide and renal calculi in patients with epilepsy: how big an issue?Current Medical Research and Opinion, 2007
- Pharmacokinetics and Drug Interactions with ZonisamideEpilepsia, 2007
- TopiramateDrugs, 2007
- Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial SeizuresEpilepsia, 2005
- Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial SeizuresEpilepsia, 2004